Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cells.
Cancer Sci
; 110(10): 3079-3088, 2019 Oct.
Article
in En
| MEDLINE
| ID: mdl-31432594
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Immunotherapy, Adoptive
/
Single-Chain Antibodies
/
Programmed Cell Death 1 Receptor
/
Receptors, Chimeric Antigen
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Cancer Sci
Year:
2019
Type:
Article
Affiliation country:
Japan